Top Markets
Coin of the day
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC
Clasificación en acciones #30394
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage... Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
Precio por acción
$0.03834
Última sincronización: 2026-08-18
Capitalización bursátil
$17.01M
Cambio (1 día)
-4.15%
Cambio (1 año)
-24.82%
País
US
Comercio Oncotelic Therapeutics, Inc. (OTLC)

Categoría

Historial del precio de la acción de Oncotelic Therapeutics, Inc. (OTLC)
Precio más alto de cierre: $0.04 el 2026-08-01

Precio más bajo de cierre: $1.13K el 1993-08-01
Historial del precio de la acción de Oncotelic Therapeutics, Inc. desde 1993 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -32.69%
2025 190.53%
2024 -20.32%
2023 -22.41%
2022 -69.52%
2021 -23.89%
2020 10.12%
2019 94.22%
2018 -42.06%
2017 -52.99%
2016 -55.78%
2015 -50.20%
2014 -33.92%
2013 -46.34%
2012 -62.10%
2011 -75.63%
2010 -81.77%
2009 63.41%
2008 -70.61%
2007 -50.93%
2006 16.57%
2005 -22.97%
2004 -35.60%
2003 628.33%
2002 -57.82%
2001 -63.45%
2000 -53.89%
1999 80.93%
1998 -47.29%
1997 -25.80%
1996 133.79%
1995 86.60%
1994 -25.42%
1993 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.89 35.09%
US
$996.61 51.72%
NL
$115.52 -20.64%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE